Machine Translation Resurrected

Machine Translation: Theoretical and Methodological Issues. Sergei Nirenburg, ed. Cambridge University Press, New York, 1987. 350 pp. $49.50 HB, $17.95 PB. Machine translation was proposed by Warren Weaver in 1947 for the newly developed computer. The proposal was pursued because language—a system of symbols usually called signs—seemed manipulable in the same manner as the system of number symbols. During World War II, moreover, translation was a major concern for military and diplo

Written byWinfred Lehmann
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

There were massive problems. Linguistics was a new science, not yet recognized as an independent field meriting university departments. Grammars and dictionaries were totally inadequate. Software was developed for the much simpler number system; it achieved limited success on the cumbersome pre-transistorized hardware. Then, after a decade of research, funding was abruptly cut off in response to recommendations by a National Academy of Sciences committee headed by John Pierce, a non-linguist, and funded by the National Science Foundation. While some support continued, NSF gave no further attention to machine translation until 1985, when it co-sponsored a conference with the Association for Computational Linguistics at Colgate University. Most of the papers in this volume are revised versions of those presented at the conference.

The editor, Sergei Nirenburg of the International Center on Machine Translation at Carnegie-Mellon University, indicates in the opening pages that the book deals largely with theory and procedures. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies